BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$140M |
| 2 |
iShares US Financials ETF
IYF
|
+$119M |
| 3 |
AGN
Allergan plc
AGN
|
+$100M |
| 4 |
Charter Communications
CHTR
|
+$95.1M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$82.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
State Street SPDR S&P Biotech ETF
XBI
|
+$909M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$623M |
| 4 |
Apple
AAPL
|
+$389M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.73% |
| 2 | Financials | 5.47% |
| 3 | Healthcare | 4.96% |
| 4 | Consumer Discretionary | 4.64% |
| 5 | Industrials | 3.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BELFB
3351
Bel Fuse Inc Class B
BELFB
$4.23B
| $70.5K | ﹤0.01% |
3,437
+1,863
| +118% | +$30.6K |
|
3352
National Bankshares
NKSH
$271M
| $70.5K | ﹤0.01% |
1,568
+497
| +46% | +$21.3K |
|
|
EEX
3353
DELISTED
Emerald Holding
EEX
| $70.4K | ﹤0.01% |
6,675
+2,147
| +47% | +$21.3K |
|
3354
Johnson Outdoors
JOUT
$509M
| $70.3K | ﹤0.01% |
917
+129
| +16% | +$8.44K |
|
3355
Intrepid Potash
IPI
$482M
| $70.2K | ﹤0.01% |
2,592
+807
| +45% | +$21.9K |
|
3356
Oppenheimer Holdings
OPY
$1.22B
| $70.2K | ﹤0.01% |
2,556
+1,002
| +64% | +$27.9K |
|
|
MCBC
3357
DELISTED
Macatawa Bank Corp
MCBC
| $69.8K | ﹤0.01% |
6,274
+2,090
| +50% | +$22.3K |
|
3358
Southern Missouri Bancorp
SMBC
$849M
| $69.5K | ﹤0.01% |
1,811
+584
| +48% | +$21.6K |
|
3359
Bristow Group
VTOL
$1.36B
| $69.3K | ﹤0.01% |
3,408
+1,802
| +112% | +$35.7K |
|
3360
Blue Bird Corp
BLBD
$2.06B
| $69.2K | ﹤0.01% |
3,017
+563
| +23% | +$11.2K |
|
|
AXDX
3361
DELISTED
Accelerate Diagnostics
AXDX
| $69K | ﹤0.01% |
408
-4,923
| -92% | -$813K |
|
3362
Peapack-Gladstone Financial
PGC
$823M
| $68.9K | ﹤0.01% |
2,229
-842
| -27% | -$24.8K |
|
3363
Cerus
CERS
$570M
| $68.7K | ﹤0.01% |
16,272
-5,254
| -24% | -$22.6K |
|
3364
Travere Therapeutics
TVTX
$5.79B
| $68.6K | ﹤0.01% |
4,833
-1,731
| -26% | -$22.1K |
|
|
GDEN
3365
DELISTED
Golden Entertainment
GDEN
| $68.6K | ﹤0.01% |
3,569
+711
| +25% | +$11.6K |
|
3366
TherapeuticsMD
TXMD
$24.2M
| $68.4K | ﹤0.01% |
566
-88
| -13% | -$12.7K |
|
|
BHR
3367
Braemar Hotels & Resorts
BHR
$140M
| $68.4K | ﹤0.01% |
7,662
+2,905
| +61% | +$27.2K |
|
3368
Beazer Homes USA
BZH
$874M
| $68.4K | ﹤0.01% |
4,841
+66
| +1% | +$1K |
|
3369
Alpha and Omega Semiconductor
AOSL
$915M
| $68.1K | ﹤0.01% |
5,003
+1,834
| +58% | +$23.2K |
|
3370
Krystal Biotech
KRYS
$9.8B
| $68.1K | ﹤0.01% |
1,229
-89
| -7% | -$4.37K |
|
|
OMN
3371
DELISTED
OMNOVA Solutions Inc.
OMN
| $67.3K | ﹤0.01% |
6,660
-335
| -5% | -$3.38K |
|
3372
Ardmore Shipping
ASC
$705M
| $66.9K | ﹤0.01% |
7,397
+2,104
| +40% | +$17.5K |
|
|
STEL
3373
DELISTED
Stellar Bancorp
STEL
| $66.9K | ﹤0.01% |
2,151
-762
| -26% | -$22.4K |
|
3374
Green Brick Partners
GRBK
$3.03B
| $66.4K | ﹤0.01% |
5,783
+1,828
| +46% | +$20K |
|
|
CBL
3375
DELISTED
CBL& Associates Properties, Inc.
CBL
| $66.4K | ﹤0.01% |
63,206
+34,398
| +119% | +$45K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2019 Portfolio in Review
As of Q4 2019, BNP Paribas Financial Markets held 4,613 positions worth $54.9B, down 2.5% from $56.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
BNP Paribas Financial Markets withdrew a net $10.1B in Q4 2019, closing 185 positions and reducing 1,420 holdings. Its most notable exit was Celgene Corp, an estimated $56.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.
Against the trend, BNP Paribas Financial Markets opened a new position in iShares US Financials ETF worth $124M.
- BNP Paribas Financial Markets's largest Q4 2019 buy was iShares US Financials ETF: 1,800,000 shares worth $124M.
- BNP Paribas Financial Markets added most to Bristol-Myers Squibb in Q4 2019, an estimated $140M increase.
- BNP Paribas Financial Markets's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- BNP Paribas Financial Markets fully exited Celgene Corp in Q4 2019, selling an estimated $56.8M.
- BNP Paribas Financial Markets's ten largest holdings make up 16% of its $54.9B portfolio in Q4 2019.
- BNP Paribas Financial Markets opened 106 new positions and closed 185 in Q4 2019.
- BNP Paribas Financial Markets's portfolio value fell 2.5% quarter-over-quarter to $54.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2019, filed 12 Feb 2020.